WDR11

Chr 10ADAR

WD repeat domain 11

Also known as: BRWD2, DR11, HH14, SRI1, WDR15

This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by gly-his and trp-asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. This gene is located in the chromosome 10q25-26 region, which is frequently deleted in gliomas and tumors of other tissues, and is disrupted by the t(10;19) translocation rearrangement in glioblastoma cells. The gene location suggests that it is a candidate gene for the tumor suppressor locus. [provided by RefSeq, Jul 2008]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismAD/ARLOEUF 0.532 OMIM phenotypes
Clinical SummaryWDR11
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
18 unique Pathogenic / Likely Pathogenic· 240 VUS of 534 total submissions
📖
GeneReview available — WDR11
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.53LOEUF
pLI 0.000
Z-score 4.70
OE 0.38 (0.280.53)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
1.80Z-score
OE missense 0.80 (0.750.86)
528 obs / 657.6 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.38 (0.280.53)
00.351.4
Missense OE?0.80 (0.750.86)
00.61.4
Synonymous OE?0.90
01.21.6
LoF obs/exp: 26 / 67.8Missense obs/exp: 528 / 657.6Syn Z: 1.17
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongWDR11-related intellectual disability and microcephalyLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.5477th %ile
GOF
0.3986th %ile
LOF
0.4627th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Literature Evidence

LOFTreatment with the Hh agonist purmorphamine partially rescues the WDR11 haploinsufficiency phenotypes.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 29263200

ClinVar Variant Classifications

534 submitted variants in ClinVar

Classification Summary

Pathogenic7
Likely Pathogenic11
VUS240
Likely Benign129
Benign137
Conflicting8
7
Pathogenic
11
Likely Pathogenic
240
VUS
129
Likely Benign
137
Benign
8
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
6
1
0
0
7
Likely Pathogenic
11
0
0
0
11
VUS
8
226
3
3
240
Likely Benign
0
7
71
51
129
Benign
0
0
126
11
137
Conflicting
8
Total2523420065532

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

40 pathogenic / likely-pathogenic (of 48) ClinVar copy-number / structural variants overlap WDR11 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

WDR11 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →